Sands Capital Management
ABMD

Sands Capital Management’s Abiomed Inc ABMD Stock Holding History

Sands Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,479,909
Closed -$480M – 79
2020
Q4 		$480M Sell
1,479,909
-15,056
-1% -$4.16M 0.91% 37
2020
Q3 		$414M Buy
1,494,965
+30,501
+2% +$8.79M 0.9% 38
2020
Q2 		$354M Buy
1,464,464
+3,610
+0.2% +$725K 0.86% 39
2020
Q1 		$212M Sell
1,460,854
-980,222
-40% -$163M 0.71% 38
2019
Q4 		$416M Buy
2,441,076
+500,246
+26% +$92.7M 1.21% 29
2019
Q3 		$345M Sell
1,940,830
-195,596
-9% -$42.3M 1.11% 30
2019
Q2 		$557M Buy
2,136,426
+835,078
+64% +$222M 1.66% 21
2019
Q1 		$372M Buy
1,301,348
+448,988
+53% +$149M 1.15% 27
2018
Q4 		$277M Buy
852,360
+408,753
+92% +$142M 0.99% 32
2018
Q3 		$200M Buy
+443,607
New +$175M 0.56% 37

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Sands Capital Management's ABMD Position: Q1 2021 in Review

Sands Capital Management sold out of Abiomed Inc (ABMD) in Q1 2021, closing a stake of 1,479,909 shares — an estimated $480M sold.

Sands Capital Management first reported a position in ABMD in Q3 2018 and held it in 10 quarters. The position peaked at $557M in Q2 2019. 487 funds tracked by Wall St. Rank hold ABMD as of Q1 2021.

  • Sands Capital Management reported no remaining Abiomed Inc position as of Q1 2021 after selling out during the quarter.
  • Sands Capital Management sold 1,479,909 Abiomed Inc shares in Q1 2021, an estimated $480M.
  • Sands Capital Management first reported a position in Abiomed Inc in Q3 2018 and held it in 10 quarters.
  • Sands Capital Management's Abiomed Inc position peaked at $557M in Q2 2019.
  • 487 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2021.

Based on Sands Capital Management's 13F filing for Q1 2021, filed 12 May 2021.